IL15 and neoplasm: developed CCL5 and IL‐15 loaded oncolytic adenovirus that could infect tumor cells to ectopically express CCL5.[96] Infected tumor cells that expressed CCL5 enhanced the effective migration of infused CAR‐T cells, which increased anti‐tumor activity.